AwardTape · Defense awards · Electronics and communications · Instruments and lab equipment · FA301624A0017
FA301624A0017: $0 blanket purchase agreement to Sysmex America, Inc
Sysmex America, Inc holds a blanket purchase agreement from Department of the Air Force with $0 obligated since Oct 2023, against a ceiling of $1.5M. Latest action May 21, 2026.
Sysmex analyzers, reagents, and consumables
| PIID | FA301624A0017 |
|---|---|
| Type | blanket purchase agreement |
| Company | Sysmex America, Inc |
| Agency | Department of the Air Force |
| Contracting office | FA3016 502 CONS CL |
| Category | Electronics and communications · Instruments and lab equipment |
| PSC | 6632 ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE |
| NAICS | 334516 ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $1.5M |
| Base date | Apr 24, 2024 |
| Latest action | May 21, 2026 |
| End date | n/a |
| Actions since Oct 2023 | 4 |
| Pricing | Set per order |
| Competition | Not reported |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| HT009025FG0230014 BPA call | Sysmex America, Inc | $25K | Alinity's chagas reagent | Defense Health Agency | Health care services | Feb 5, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial